C5 Preparing for the Threat of Multidrug-Resistant Neisseria Gonorrhoeae

Earn CE Credit for viewing the archived recordings of the 2012 STD Conference.

Deadline: April 12, 2014

For details, click Continuing Education Information

Wednesday, March 14, 2012: 10:30 AM-12:15 PM
Nicollet Grand Ballroom (C/D)
Background/Purpose: N. gonorrhoeae has developed resistance to each antibiotic recommended for treatment. Cephalosporins are the only remaining class of antibiotics that meet CDC’s recommendations for treating gonorrhea.  Recent international and US data suggest that cephalosporin-resistance may be emerging.

Objectives of Symposium: To provide an overview of N. gonorrhoeae antibiotic resistance, highlight international and US cephalosporin susceptibility trends, discuss key laboratory, treatment, and programmatic issues, and explore research needs.

Implications for Programs, Policy, and Research: In the face of the emerging threat of multidrug-resistant N. gonorrhoeae, it is critical to understand the surveillance, laboratory, treatment and program implications and address research gaps. 

10:30 AM
The Public Health Importance of N. Gonorrhoeae Resistance and Recent Surveillance Trends
Robert Kirkcaldy, MD, MPH, Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA
10:50 AM
Real Time PCR As a Surveillance Tool for Detection of N. Gonorrhoeae with a Reduced Susceptibility to Oral Cephalosporins
Mark Pandori, PhD, HCLD(ABB), Laboratory, San Francisco Department of Public Health Laboratory, San Francisco, CA
11:10 AM
N. Gonorrhoeae Culture Based Susceptibility Testing and the Limits of Molecular Detection Methods
David Trees, PhD, Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA
11:30 AM
Planning and Programmatic Responses
Susan S. Philip, MD, MPH, STD Prevention and Control Services, San Francisco Department of Public Health, San Francisco, CA
See more of: Symposium